Navigation Links
Inspiration Biopharmaceuticals Announces New Global Commercialization Agreements with Ipsen
Date:8/20/2012

CAMBRIDGE, Mass., Aug. 21, 2012 /PRNewswire/ -- Inspiration Biopharmaceuticals Inc. (Inspiration) today announced new license, development and commercialization agreements with its strategic partner, Ipsen (Euronext: IPN, ADR: IPSEY). The agreements restructure the existing partnership with Ipsen and provide Inspiration with additional funding to support development of its two investigational drugs in late-stage development for hemophilia, IB1001 and OBI-1. Under the terms of these agreements, Inspiration grants Ipsen commercialization rights for IB1001 (recombinant human factor IX) and OBI-1 (recombinant porcine factor VIII) in certain geographies. Inspiration will receive a $30 million up-front payment, with additional payments and investments linked to future development and commercial milestones, for a total potential value of $200 million. This includes a commitment from Ipsen to fund a significant percentage of Inspiration's next round of external financing.

Ipsen gains rights to commercialize IB1001 and OBI-1 in Europe, Russia, China, Australia and certain other countries, and will be responsible for future regulatory filings in those regions. Inspiration retains commercialization rights in the Americas, Japan, India, the Middle East, South Africa, Taiwan and certain other countries, as well as global development rights for all products in Inspiration's product portfolio. Each company is obligated to pay the other royalties generated by sales of OBI-1 in their respective geographies and Ipsen will pay Inspiration royalties on sales of IB1001.

Under the terms of the new agreements, after the completion of a $30 million qualified external financing Ipsen will invest an additional $20 million in Inspiration and will no longer have a call option to acquire Inspiration, giving Inspiration the ability to develop as an independent entity. Ipsen gains the right to appoint two additional Directors to Inspiration's Board.

"Durin
'/>"/>

SOURCE Inspiration Biopharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
2. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
3. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
4. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
5. Global Biopharmaceuticals Market 2011-2015
6. Keryx Biopharmaceuticals to Present at The 7th Annual JMP Securities Healthcare Conference
7. Keryx Biopharmaceuticals Announces Live Webcast of Upcoming Analyst Day
8. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
9. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
10. UBM Announces Partnership Agreement With Trade Organisation - SIPPO
11. Response Genetics, Inc. Announces Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... (PRWEB) May 22, 2013 Express ... Supplies Pty Ltd are pleased to announce a ... the Australian and New Zealand distributor of DrugCheck® onsite ... Supercar Team participated in the Austin 400 May 17-19 ... into an agreement that involves each car of the ...
(Date:5/22/2013)... 2013 Envera announced today that Michael ... Mr. McErlean has an extensive background in cell production ... his career. , Mike Matheny, President and ... have Mike join our team”. “Mike’s background is perfectly ... fermentation and downstream processing equipment”, added Matheny. “Mike’s ...
(Date:5/22/2013)... Canada (PRWEB) May 22, 2013 ... approaches for deciphering the information they encode. There ... ribosome profiling (deep sequencing of ribosome protected fragments) ... in vivo. , Keynote speakers include Dr. Jonathan ... Francisco and the Howard Hughes Medical Institute, who ...
(Date:5/21/2013)... 2013 First patients dosed with ... bromide designed using Prosonix, particle engineering platform ... of inhaled Respiratory Medicines by Design , has ... will assess its effect on lung function and the ... moderate to severe chronic obstructive pulmonary disease (COPD). The ...
Breaking Biology Technology:Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Envera Appoints Michael McErlean Fermentation Manager 2Monitoring Protein Synthesis One Codon at a Time Through Ribosome Profiling, a Webinar Hosted by Xtalks 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
... new biochip technology could eliminate animal testing in the ... in the development of new pharmaceuticals, according to new ... Institute, the University of California at Berkeley, and Solidus ... will be featured in the online Early Edition of ...
... hemostasis kit combines two important surgical tools: Baxter,s ... human thrombin ... Baxter Healthcare,Corporation today announced the Food and Drug Administration ... and human,thrombin). GELFOAM Plus is the only available hemostasis ...
... (NASDAQ: ANPI , TSX: ANP), a global ... it has submitted a 510(k),application to the U.S. ... 5-Fluorouracil-coated (5-FU) Central Venous,Catheter (CVC)., "We are ... application to,the FDA for our 5-FU CVC, as ...
Cached Biology Technology:Biochip mimics the body to reveal toxicity of industrial compounds 2Biochip mimics the body to reveal toxicity of industrial compounds 3Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit 2Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit 3Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit 4Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 2Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 3Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 4Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 5
(Date:5/22/2013)... endanger the whole organism, as they may lead to ... Munich now report how byproducts of respiration cause mispairing ... in our cells controls the form and function of ... this are encoded in the linear sequence of the ... cytosine (C), guanine (G) and thymine (T). Random changes ...
(Date:5/22/2013)... and wild plants have slowed in recent years, according ... University of Leeds and the Naturalis Biodiversity Centre in ... the diversity of species in Britain, Belgium and the ... picture brightened markedly after 1990, with a slowdown in ... wild plants. , Professor Bill Kunin, Professor ...
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... Boston University School of Medicine (BUSM) faculty members, ... and psychiatry and Michael Silverstein, MD, an associate ... National Institute of Mental Health (NIMH) Biobehavioral Research ... ten other investigators from around the country. The ...
... everyday life and are involved in leisure activities rarely ... University of Gothenburg, Sweden. Occupational therapist Christina Andersson, ... life affects alcohol consumption as part of the wider ... has been ongoing at the Sahlgrenska Academy since the ...
... system can affect healthy people,s personality traits as well ... behaviour, reveals a thesis from the University of Gothenburg, ... and is responsible for defending humans against infection as ... therefore vital for our survival. Research has demonstrated that ...
Cached Biology News:Boston University School of Medicine researchers receive NIMH brain awards 2Women involved in leisure activities drink less alcohol 2Genes of the immune system are associated with increased risk of mental illness 2
... for maximum packaging efficiencies of T7Select vectors ... (> 109 pfu/g with control DNA) make ... at least 5 107 recombinant plaques ... from a specially designed phage that reduces ...
... Tecan has 20 years of expertise in ... and still offers the most powerful systems ... up to 40 000 in-microplate tests requiring ... integration of different modules (such as worktable ...
... Luciferase-based ENGENISTM (Entire Gene/cDNA or Isolated ... provide a quantitative approach for evaluation of ... serve as an efficient target for RNA ... algorithms are not perfect, leaving the probability ...
... pre-validated SNP sequencing services ... within 93 genes including ... more than 80 tyrosine ... were developed and validated ...
Biology Products: